Vitamin D and critical illness outcomes

Area of Science:

• Critical care medicine
• Endocrinology
• Nutritional science

Background:

• Low vitamin D levels are linked to adverse outcomes in critical care.
• The efficacy of vitamin D supplementation in all ICU patients remains unclear.
• Current research focuses on identifying specific patient groups who benefit from high-dose vitamin D.

Purpose of the Study:

• To evaluate the impact of high-dose vitamin D3 supplementation on outcomes in critically ill patients.
• To determine if vitamin D supplementation can alter adverse outcomes in the intensive care unit (ICU) population.

Main Methods:

• The VITdAL-ICU trial was a randomized, double-blind, placebo-controlled, single-center study.
• The trial involved 475 heterogeneous critically ill patients.
• Participants received high-dose oral vitamin D3 or a placebo.

Main Results:

• Overall mortality and hospital length of stay were not improved by vitamin D3 supplementation.
• A secondary outcome analysis revealed that high-dose vitamin D3 improved mortality in patients with severe vitamin D deficiency.
• No significant difference in hospital length of stay was observed between groups.

Conclusions:

• Vitamin D supplementation may offer a personalized therapy for critical illness.
• Further research into vitamin D's role in gene regulation, metabolomics, transcriptomics, and epigenetics is promising for understanding critical illness outcomes.